Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Clin Infect Dis ; 50 Suppl 1: S26-33, 2010 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-20067390

RESUMO

BACKGROUND: The rationale and lessons learned through the evolution of the National Survey for the Susceptibility of Bacteroides fragilis Group from its initiation in 1981 through 2007 are reviewed here. The survey was conceived in 1980 to track emerging antimicrobial resistance in Bacteroides species. METHODS: Data from the last 11 years of the survey (1997-2007), including 6574 isolates from 13 medical centers, were analyzed for in vitro antimicrobial resistance to both frequently used and newly developed anti-anaerobic agents. The minimum inhibitory concentrations of the antibiotics were determined using agar dilution in accordance with Clinical and Laboratory Standards Institute recommendations. RESULTS: The analyses revealed that the carbapenems (imipenem, meropenem, ertapenem, and doripenem) and piperacillin-tazobactam were the most active agents against these pathogens, with resistance rates of 0.9%-2.3%. In the most recent 3 years of the survey (2005-2007), resistance to some agents was shown to depend on the species, such as ampicillin-sulbactam against Bacteroides distasonis (20.6%) and tigecycline against Bacteroides uniformis and Bacteroides eggerthii ( approximately 7%). Very high resistance rates (>50%) were noted for moxifloxacin and trovafloxacin, particularly against Bacteroides vulgatus. During that period of study, non-B. fragilis Bacteroides species had >40% resistance to clindamycin. Metronidazole-resistant Bacteroides strains were also first reported during that period. CONCLUSIONS: In summary, resistance to antibiotics was greater among non-B. fragilis Bacteroides species than among B. fragilis and was especially greater among species with a low frequency of isolation, such as Bacteroides caccae and B. uniformis. The emergence of resistance among the non-B. fragilis Bacteroides species underscores the need for speciation of B. fragilis group isolates and for clinicians to be aware of associations between species and drug resistance.


Assuntos
Antibacterianos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Bacteroides fragilis/efeitos dos fármacos , Bacteroides/efeitos dos fármacos , Farmacorresistência Bacteriana , Bacteriemia/microbiologia , Bacteroides/classificação , Bacteroides/isolamento & purificação , Infecções por Bacteroides/microbiologia , Bacteroides fragilis/isolamento & purificação , Coleta de Dados , Humanos , Testes de Sensibilidade Microbiana
2.
J Clin Invest ; 110(1): 101-8, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12093893

RESUMO

Excessive production of the complement activation product C5a appears to be harmful during the development of sepsis in rodents. Little is known about the role of the C5a receptor (C5aR) and its presence in different organs during sepsis. Using the cecal ligation/puncture (CLP) model in mice, we show here that C5aR immunoreactivity was strikingly increased in lung, liver, kidney, and heart early in sepsis in both control and neutrophil-depleted mice. C5aR mRNA expression in these organs was also significantly increased during sepsis. Immunohistochemical analysis revealed patterns of increased C5aR expression in parenchymal cells in all four organs following CLP. Mice injected at the start of CLP with a blocking IgG to C5aR (alphaC5aR) showed dramatically improved survival when compared with animals receiving nonspecific IgG, as did mice injected with alphaC5a. In alphaC5aR-treated mice, serum levels of IL-6 and TNF-alpha and bacterial counts in various organs were significantly reduced during CLP when compared with control CLP animals. These studies demonstrate for the first time that C5aR is upregulated in lung, liver, kidney, and heart during the early phases of sepsis and that blockade of C5aR is highly protective from the lethal outcome of sepsis.


Assuntos
Antígenos CD/metabolismo , Receptores de Complemento/metabolismo , Sepse/imunologia , Animais , Anticorpos/administração & dosagem , Antígenos CD/genética , Modelos Animais de Doenças , Imuno-Histoquímica , Rim/imunologia , Fígado/imunologia , Pulmão/imunologia , Depleção Linfocítica , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Miocárdio/imunologia , Neutrófilos/imunologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptor da Anafilatoxina C5a , Receptores de Complemento/antagonistas & inibidores , Receptores de Complemento/genética , Sepse/genética , Sepse/prevenção & controle , Distribuição Tecidual , Regulação para Cima
3.
Obstet Gynecol ; 101(1): 74-9, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12517649

RESUMO

Despite antibiotic prophylaxis for at-risk mothers during labor and delivery, group B streptococcus still causes substantial morbidity and mortality among newborns. Resistance to antibiotics recommended for penicillin-allergic pregnant women, such as erythromycin and clindamycin, has increased. A better understanding of factors associated with group B streptococcus resistance is essential to effectively prevent group B streptococcus disease.A total of 117 sequential group B streptococcus isolates were obtained between August 1999 and March 2000 from pregnant women at the University of Michigan Medical Center. Serotype and susceptibility to ten antimicrobials using disk diffusion with E-test for confirmation were determined, and the association between several host factors and colonization with a resistant strain was evaluated. Group B streptococcus was frequently resistant to erythromycin (29%) and clindamycin (21%) but was susceptible to all other antimicrobials tested. A stepwise logistic regression model revealed that black ethnicity (P =.02) and carriage of a serotype V strain (P =.01) were associated with group B streptococcus resistance. Among this population of pregnant women, black ethnicity and serotype V were the strongest predictors of colonization with an erythromycin- or clindamycin-resistant group B streptococcus strain. A better understanding of factors associated with antibiotic resistance is needed to minimize group B streptococcus disease risks and to maximize effective chemoprophylaxis.


Assuntos
Farmacorresistência Bacteriana Múltipla , Complicações Infecciosas na Gravidez/tratamento farmacológico , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus agalactiae/efeitos dos fármacos , Adolescente , Adulto , Feminino , Humanos , Testes de Sensibilidade Microbiana , Gravidez
4.
J Womens Health (Larchmt) ; 12(10): 979-89, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14709186

RESUMO

OBJECTIVE: To assess associations between female and male factors and the risk of recurring Candida vulvovaginitis. METHODS: A prospective cohort study of 148 women with Candida vulvovaginitis and 78 of their male sexual partners was conducted at two primary care practices in the Ann Arbor, Michigan, area. RESULTS: Thirty-three of 148 women developed at least one further episode of Candida albicans vulvovaginitis within 1 year of follow-up. Cultures of Candida species from various sites of the woman (tongue, feces, vulva, and vagina) and from her partner (tongue, feces, urine, and semen) did not predict recurrences. Female factors associated with recurrence included recent masturbating with saliva (hazard ratio 2.66 [95% CI 1.17-6.06]) or cunnilingus (hazard ratio 2.94 [95% CI 1.12-7.68]) and ingestion of two or more servings of bread per day (p

Assuntos
Candidíase Vulvovaginal/microbiologia , Candidíase Vulvovaginal/transmissão , Parceiros Sexuais , Vulvovaginite/microbiologia , Adulto , Candidíase Vulvovaginal/prevenção & controle , Portador Sadio/tratamento farmacológico , Portador Sadio/microbiologia , Fezes/microbiologia , Feminino , Seguimentos , Humanos , Masculino , Masturbação , Michigan , Análise Multivariada , Razão de Chances , Pênis/microbiologia , Modelos de Riscos Proporcionais , Estudos Prospectivos , Recidiva , Saliva/microbiologia , Fatores de Tempo , Língua/microbiologia , Resultado do Tratamento , Vagina/microbiologia , Vulvovaginite/prevenção & controle
5.
J Infect ; 49(2): 126-35, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15236919

RESUMO

OBJECTIVE: The emergence of multidrug resistance within Streptococcus pneumoniae population was analysed, correlating penicillin resistance Pen(R) with secondary antibiotic resistance, capsular serotype, and genetic diversity among isolates. METHODS: DNA fingerprinting, following macro-restriction enzyme digestion and pulse field gel electrophoresis (PFGE), and restriction fragment analysis of the PBP 2b gene, following PCR amplification, were performed on the Pen(R) S. pneumoniae, among 377 clinical isolates obtained from the clinical microbiology laboratory (University of Michigan Medical Center). RESULTS: Overall 35% of the isolates were Pen(R) of which 45% demonstrated high-level penicillin (Pen(R)-R, MIC>1). Respiratory isolates were more likely to be Pen(R) (p <0.001) than non-respiratory isolates and the rate of Pen(R)-R was significantly increased in children <10 years of age (59.6%, p <0.02). Secondary antibiotic resistance was more frequently associated with Pen(R)-R. Genomic DNA fingerprinting analysis and restriction fragment analysis of the PBP 2b gene demonstrated genomic divergence with discrete conserved pattern in the PBP 2b gene among the resistant isolates. CONCLUSION: The emergence of multidrug resistance in the S. pneumoniae population in SE Michigan is not due to expansion of a single or limited number of resistant clones, is occurring most frequently in the paediatric population and is associated with a decreased susceptibility to penicillin.


Assuntos
Streptococcus pneumoniae/genética , Proteínas de Bactérias/genética , Proteínas de Transporte/genética , Distribuição de Qui-Quadrado , Impressões Digitais de DNA , Farmacorresistência Bacteriana , Eletroforese em Gel de Campo Pulsado , Variação Genética , Hexosiltransferases/genética , Humanos , Michigan , Muramilpentapeptídeo Carboxipeptidase/genética , Resistência às Penicilinas/genética , Proteínas de Ligação às Penicilinas , Peptidil Transferases/genética , Polimorfismo de Fragmento de Restrição , Streptococcus pneumoniae/efeitos dos fármacos
6.
Antimicrob Agents Chemother ; 50(6): 2244-7, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16723596

RESUMO

We assessed infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli or Klebsiella spp. treated with piperacillin-tazobactam to determine if the susceptibility breakpoint predicts outcome. Treatment was successful in 10 of 11 nonurinary infections from susceptible strains and in 2 of 6 infections with MICs of >16/4 mug/ml. All six urinary infections responded to treatment regardless of susceptibility.


Assuntos
Antibacterianos/farmacologia , Escherichia coli/efeitos dos fármacos , Klebsiella oxytoca/efeitos dos fármacos , Klebsiella pneumoniae/efeitos dos fármacos , Inibidores de beta-Lactamases , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/microbiologia , Escherichia coli/enzimologia , Escherichia coli/isolamento & purificação , Feminino , Humanos , Klebsiella oxytoca/enzimologia , Klebsiella oxytoca/isolamento & purificação , Klebsiella pneumoniae/enzimologia , Klebsiella pneumoniae/isolamento & purificação , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Ácido Penicilânico/análogos & derivados , Ácido Penicilânico/farmacologia , Ácido Penicilânico/uso terapêutico , Piperacilina/farmacologia , Piperacilina/uso terapêutico , Combinação Piperacilina e Tazobactam , Estudos Retrospectivos , Fatores de Tempo , Resultado do Tratamento , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/microbiologia
7.
Injury ; 36(12): 1449-52, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16243337

RESUMO

The purpose of this study was to evaluate the effectiveness of standard iodine surgical scrubs to remove bacteria from external fixator components. Sterile adjustable external fixation clamps, Schanz pins, and carbon fibre rods were coated with a sterile protein solution and immersed in solution of coagulase negative Staphylococcus (10(3)organisms/ml). They were then decontaminated in standard fashion using a povidone iodine scrub and paint solution. After neutralisation the components were sonicated, serially diluted, plated on blood agar, and incubated for 24h. Unassembled external fixation components were examined individually, and as assembled pin-rod-clamp constructs with and without manipulation of the clamp. Of the three external fixation components (pins, rods, clamps) the highest number of bacterial colony forming units was seen on the external fixation clamps. Manipulation of the assembled construct significantly increased the mean bacterial colony counts compared to the assembled non-manipulated construct (p=0.0007). Standard surgical preparation does not remove all bacteria from external fixators during subsequent operative procedures.


Assuntos
Anti-Infecciosos Locais , Descontaminação/métodos , Contaminação de Equipamentos , Fixadores Externos , Povidona-Iodo , Pinos Ortopédicos , Contagem de Colônia Microbiana , Desenho de Equipamento , Fômites , Desinfecção das Mãos , Humanos , Infecção da Ferida Cirúrgica/prevenção & controle
8.
J Clin Microbiol ; 40(9): 3326-33, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12202574

RESUMO

A total of 640 vancomycin-resistant Enterococcus faecium (VRE) isolates, which were obtained between 1994 and 1999 from the Medical School Hospital of the University of Michigan, Ann Arbor, were used in this study. Of the 640 strains, 611 and 29 were VanA and VanB VRE, respectively, based on PCR analysis. Four hundred ninety-two (77%) of the strains exhibited resistance to concentrations of gentamicin from 64 micro g/ml (MIC) to more than 1,024 micro g/ml (MIC). The gentamicin resistance of each of 261 (53%) of the 492 gentamicin-resistant strains was transferred to E. faecium at a frequency of about 10(-5) to 10(-6) per donor cell in broth mating. More than 90% of vancomycin resistances of the 261 strains cotransferred with the gentamicin resistances to E. faecium strains by filter mating. The conjugative gentamicin resistance plasmids were identified and were classified into five types (A through E) with respect to their EcoRI restriction profiles. The transfer frequencies of each type of plasmid between E. faecium strains or Enterococcus faecalis strains were around 10(-3) to 10(-5) per donor cell or around 10(-6) to 10(-7) per donor cell, respectively, in broth mating. Type A and type B were the most frequently isolated, at an isolation frequency of about 40% per VRE isolate harboring the gentamicin resistance conjugative plasmid. The plasmids did not show any homology in Southern hybridization with the pheromone-responsive plasmids and broad-host-range plasmids pAMbeta1 and pIP501. The EcoRI or NdeI restriction fragments of each type of plasmids hybridized to the conjugative gentamicin resistance plasmid pMG1 (65.1 kb), which was originally isolated from an E. faecium clinical isolate, and transfer efficiently in broth mating.


Assuntos
Antibacterianos/farmacologia , Conjugação Genética , Enterococcus faecium/efeitos dos fármacos , Gentamicinas/farmacologia , Plasmídeos/genética , Resistência a Vancomicina , Meios de Cultura , Farmacorresistência Bacteriana/genética , Enterococcus faecium/genética , Transferência Genética Horizontal , Hibridização de Ácido Nucleico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA